Redmile Group, LLC - Dec 20, 2024 SCHEDULE 13D/A Report for FATE THERAPEUTICS INC Common Stock, $0.001 par value per share (FATE)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
FATE THERAPEUTICS INC Common Stock, $0.001 par value per share
Symbol
FATE
Shares outstanding
120M shares
Disclosed Ownership
17.8M shares
Ownership
14.9%
Form type
SCHEDULE 13D/A
Date filed
12/26/2024, 09:00 PM
Date of event
Dec 20, 2024
Next filing
Jul 3, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 14.9% 17.8M 0 17.8M /s/ Jeremy C. Green Jeremy C. Green/Managing Member 0001425738
Jeremy C. Green 14.9% 17.8M 0 17.8M /s/ Jeremy C. Green Jeremy C. Green 0001650527
RedCo II Master Fund, L.P. 8.5% 9.79M 0 9.79M /s/ Jeremy C. Green - REDCO II (GP), LLC, ITS GENERAL PARTNER Jeremy C. Green/Managing Member 0001921783